Personalis shows promise in cancer detection but is years away from profitability. Read why PSNL stock is rated a hold with ...

As Alnylam Pharmaceuticals approaches its highly anticipated March 23 FDA decision date for a potential expansion of Amvuttra ...

Blueprint Medicines (BPMC) sees strong AYVAKIT growth, 2025 revenue guidance at $680M-$710M. Discover insights on their market expansion & $2B 2030 vision.

TD Cowen analyst Yaron Werber raised the firm’s price target on Ascendis Pharma (ASND) to $162 from $153 and keeps a Buy rating on the shares.

If a language can be used to build web scrapers, it definitely needs to provide a graceful data visualization library. --- by dongdong. In the Golang ecosystem, there are not many choices for data ...

Louvain-La-Neuve, Belgium, and Paris, France, 7 February 2025 - Framatome, an international leader in nuclear energy committed to developing products and services for the healthcare industry, and IBA ...

Eyeing an expected leap in demand for contrast media—used in X-rays, CT scans and more—GE HealthCare is upping its stake in the Emerald Isle. The company is pumping $138 million into its ...

This is an example of having a growth mindset. Someone who has a fixed mindset, on the other hand, might sit down to paint for the first time, become frustrated that their painting looks nothing like ...

In Eagan, with 2024 marking a significant year in transforming defunct business campuses into lively new community hotspots. In a city that's nearly outgrown its expansion chrysalis, the name of ...

"We delivered strong second quarter financial results while taking significant strategic and operational actions to position us for future growth," said Jason Hollar, CEO of Cardinal Health.

Edwards Lifesciences shares rise as analyst upgrades stock, citing TAVR growth, margin expansion, and strategic business changes for 2025.

Steris (STE) is expected to deliver a year-over-year increase in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a ...